Fundraising FoxARCALIS
1 known investors
Find your way into ARCALIS
Sign up to see every warm intro you have to ARCALIS
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ARCALIS team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
A US-Japan joint venture established in 2021 between Axcelead and US-based Arcturus Therapeutics for domestic mRNA drug/vaccine manufacturing, with sites in Minamisoma (Fukushima) and Kashiwanoha (Chiba).
Investors · 1
Frequently asked questions
- What does ARCALIS do?
- A US-Japan joint venture established in 2021 between Axcelead and US-based Arcturus Therapeutics for domestic mRNA drug/vaccine manufacturing, with sites in Minamisoma (Fukushima) and Kashiwanoha (Chiba).
- Who are ARCALIS's investors?
- ARCALIS's investors include Whiz Partners Inc..